1. Sorafenib in advanced clear-cell renal-cell carcinoma

Donald L. Trump

Tài liệu tham khảo

Ratain, 2006, Phase II, placebo-controlled, randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma, J Clin Oncol, 24, 2505, 10.1200/JCO.2005.03.6723